Switch theme
Sign up to access all valuation multiples
Odontoprev SA is engaged in providing private dental care plans. The firm operates in three segments which include Corporate, Small And Medium-Sized Enterprises, Individual, and other.
1987
n/a
LTM Revenue $409M
LTM EBITDA $126M
$971M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Odontoprev has a last 12-month revenue (LTM) of $409M and a last 12-month EBITDA of $126M.
In the most recent fiscal year, Odontoprev achieved revenue of $401M and an EBITDA of $189M.
Odontoprev expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Odontoprev valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $409M | XXX | $401M | XXX | XXX | XXX |
| Gross Profit | $252M | XXX | $138M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $126M | XXX | $189M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 47% | XXX | XXX | XXX |
| EBIT | $117M | XXX | $119M | XXX | XXX | XXX |
| EBIT Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| Net Profit | $95.9M | XXX | $94.7M | XXX | XXX | XXX |
| Net Margin | 23% | XXX | 24% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Odontoprev's stock price is BRL 11 (or $2).
Odontoprev has current market cap of BRL 6.0B (or $1.1B), and EV of BRL 5.5B (or $971M).
See Odontoprev trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $971M | $1.1B | XXX | XXX | XXX | XXX | $0.17 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Odontoprev has market cap of $1.1B and EV of $971M.
Odontoprev's trades at 2.4x EV/Revenue multiple, and 5.1x EV/EBITDA.
Equity research analysts estimate Odontoprev's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Odontoprev has a P/E ratio of 11.0x.
See valuation multiples for Odontoprev and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $971M | XXX | $971M | XXX | XXX | XXX |
| EV/Revenue | 2.4x | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 7.7x | XXX | 5.1x | XXX | XXX | XXX |
| EV/EBIT | 8.3x | XXX | 8.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 11.0x | XXX | 11.1x | XXX | XXX | XXX |
| EV/FCF | 13.2x | XXX | 10.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOdontoprev's last 12 month revenue growth is 6%
Odontoprev's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Odontoprev's rule of 40 is 44% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Odontoprev's rule of X is 46% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Odontoprev and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 47% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | -4% | XXX | XXX | XXX |
| Rule of 40 | 44% | XXX | 53% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 46% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Odontoprev acquired XXX companies to date.
Last acquisition by Odontoprev was XXXXXXXX, XXXXX XXXXX XXXXXX . Odontoprev acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Odontoprev founded? | Odontoprev was founded in 1987. |
| Where is Odontoprev headquartered? | Odontoprev is headquartered in Brazil. |
| Is Odontoprev publicy listed? | Yes, Odontoprev is a public company listed on BVMF. |
| What is the stock symbol of Odontoprev? | Odontoprev trades under ODPV3 ticker. |
| When did Odontoprev go public? | Odontoprev went public in 2006. |
| Who are competitors of Odontoprev? | Similar companies to Odontoprev include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Odontoprev? | Odontoprev's current market cap is $1.1B |
| What is the current revenue of Odontoprev? | Odontoprev's last 12 months revenue is $409M. |
| What is the current revenue growth of Odontoprev? | Odontoprev revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Odontoprev? | Current revenue multiple of Odontoprev is 2.4x. |
| Is Odontoprev profitable? | Yes, Odontoprev is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Odontoprev? | Odontoprev's last 12 months EBITDA is $126M. |
| What is Odontoprev's EBITDA margin? | Odontoprev's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of Odontoprev? | Current EBITDA multiple of Odontoprev is 7.7x. |
| What is the current FCF of Odontoprev? | Odontoprev's last 12 months FCF is $73.3M. |
| What is Odontoprev's FCF margin? | Odontoprev's last 12 months FCF margin is 18%. |
| What is the current EV/FCF multiple of Odontoprev? | Current FCF multiple of Odontoprev is 13.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
